Literature DB >> 16392789

Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disorders.

Simon C Goodacre1, Leslie J Street, David J Hallett, James M Crawforth, Sarah Kelly, Andrew P Owens, Wesley P Blackaby, Richard T Lewis, Joanna Stanley, Alison J Smith, Pushpinder Ferris, Bindi Sohal, Susan M Cook, Andrew Pike, Nicola Brown, Keith A Wafford, George Marshall, José L Castro, John R Atack.   

Abstract

A series of high-affinity GABA(A) agonists with good oral bioavailability in rat and dog and functional selectivity for the GABA(A)alpha2 and -alpha3 subtypes is reported. The 7-trifluoromethylimidazopyrimidine 14g and the 7-propan-2-olimidazopyrimidine 14k are anxiolytic in both conditioned and unconditioned animal models of anxiety with minimal sedation observed at full BZ binding site occupancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16392789     DOI: 10.1021/jm051065l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Hydromagnesite sheets impregnated with cobalt-ferrite magnetic nanoparticles as heterogeneous catalytic system for the synthesis of imidazo[1,2-a]pyridine scaffolds.

Authors:  Deepika Geedkar; Ashok Kumar; Kranti Kumar; Pratibha Sharma
Journal:  RSC Adv       Date:  2021-07-01       Impact factor: 4.036

2.  Computer aided drug discovery of highly ligand efficient, low molecular weight imidazopyridine analogs as FLT3 inhibitors.

Authors:  Brendan Frett; Nick McConnell; Catherine C Smith; Yuanxiang Wang; Neil P Shah; Hong-yu Li
Journal:  Eur J Med Chem       Date:  2015-02-28       Impact factor: 6.514

3.  3-(2-Chloro-ethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one.

Authors:  Jerry P Jasinski; Ray J Butcher; Q N M Hakim Al-Arique; H S Yathirajan; B Narayana
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-25

4.  Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models.

Authors:  Felix M Rivas; James P Stables; Lauren Murphree; Rahul V Edwankar; Chitra R Edwankar; Shengming Huang; Hiteshkumar D Jain; Hao Zhou; Samarpan Majumder; Subramanian Sankar; Bryan L Roth; Joachim Ramerstorfer; Roman Furtmüller; Werner Sieghart; James M Cook
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

5.  The pseudo-Michael reaction of 1-aryl-4,5-dihydro-1H-imidazol-2-amines with ethyl ethoxymethylenecyanoacetate.

Authors:  Agnieszka A Kaczor; Urszula Kijkowska-Murak; Kalevi Pihlaja; Jari Sinkkonen; Waldemar Wysocki; Zbigniew Karczmarzyk; Dariusz Matosiuk
Journal:  Monatsh Chem       Date:  2013-05-14       Impact factor: 1.451

6.  Synthesis, central nervous system activity, and structure-activity relationship of 1-aryl-6-benzyl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones.

Authors:  Marzena Rządkowska; Elżbieta Szacoń; Agnieszka A Kaczor; Sylwia Fidecka; Ewa Kędzierska; Dariusz Matosiuk
Journal:  Med Chem Res       Date:  2014-03-27       Impact factor: 1.965

7.  ClassyFire: automated chemical classification with a comprehensive, computable taxonomy.

Authors:  Yannick Djoumbou Feunang; Roman Eisner; Craig Knox; Leonid Chepelev; Janna Hastings; Gareth Owen; Eoin Fahy; Christoph Steinbeck; Shankar Subramanian; Evan Bolton; Russell Greiner; David S Wishart
Journal:  J Cheminform       Date:  2016-11-04       Impact factor: 5.514

8.  Metal-free C-H arylation of imidazoheterocycles with aryl hydrazines.

Authors:  Sourav Jana; Sadhanendu Samanta; Avik K Bagdi; Valerii Z Shirinian; Alakananda Hajra
Journal:  RSC Adv       Date:  2018-04-03       Impact factor: 3.361

9.  Pharmacological Properties of DOV 315,090, an ocinaplon metabolite.

Authors:  Dmytro Berezhnoy; Maria C Gravielle; Scott Downing; Emmanuel Kostakis; Anthony S Basile; Phil Skolnick; Terrell T Gibbs; David H Farb
Journal:  BMC Pharmacol       Date:  2008-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.